Medical Device News Magazine

Interventional Orthopedic Solutions Rochester Enters Into a Partnership with Regenexx®

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Interventional Orthopedic Solutions Rochester is establishing its commitment to excellence in the field of Regenerative Orthopedics by entering into a partnership with Regenexx®, a worldwide network of specially trained physicians providing advanced, research-driven, regenerative orthopedic treatments.

The alliance brings cutting-edge, non-surgical orthopedic treatments to Minnesota residents suffering from sports injuries, spine pain, or degenerative diseases such as osteoarthritis.

“Being selected to represent the Regenexx brand in Minnesota speaks to the quality, skill, and care that we provide our patients,” said Catherine McBride, co-founder of the Rochester-based clinic. “Interventional Orthopedic Solutions is focused on providing the highest level of non-surgical orthopedic care in Minnesota and our partnership with Regenexx helps us achieve that goal.”

Interventional Orthopedic Solutions Rochester was founded by Dr. Russell Bergum, a long-time Minnesotan and a specialist in regenerative medicine and interventional orthopedics, and is focused on the treatment of musculoskeletal injuries and degenerative orthopedic conditions.

“All of our procedures are based on published, peer-reviewed research and incorporate the extensive Regenexx outcomes database tracking patient results from 2005 to the present, to guide treatment plans,” said Dr. Bergum, founder of IOS-Rochester. “Our goal is to get you back into doing the things you love to do. This is now possible through the state-of-the-art non-surgical orthobiologic treatments that we offer.”

Interventional Orthobiologics is a specialty that focuses on using your body’s natural healing agents to treat orthopedic injuries with the goal of reducing pain and improving joint function. The variety of orthobiologics available to Regenexx physicians, such as bone marrow aspirate concentrate (which contains stem cells) and platelet-rich plasma (PRP), allow them to create a treatment plan to best support your recovery. Regenexx procedures can be used in the treatment of conditions such as arthritis, back pain, and injury to ligaments, tendons, cartilage, spinal discs, or bones.

Regenexx physicians are required to have extensive experience and training in performing precise injection-based procedures using image guidance for a range of body parts and injuries. With strict acceptance criteria, Regenexx only chooses the most qualified physicians to join their network. Interventional Orthopedic Solutions Dr. Russell Bergum is ranked among them.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”